Globular adiponectin as a complete mesoangioblast regulator: Role in proliferation, survival, motility, and skeletal muscle differentiation

Molecular Biology of the Cell

Volumn 21, Issue 6, 2010, Pages 848-859

  Fiaschi, Tania ^a   Tedesco, Francesco Saverio ^b,c   Giannoni, Elisa ^a   Diaz Manera, Jordi ^b,d,e   Parri, Matteo ^a   Cossu, Giulio ^b,f   Chiarugi, Paola ^a,g  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^f UNIVERSITY OF MILAN   (Italy)

^g Istituto Interuniversitario di Miologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; STEM CELL FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANOIKIS; APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL HOMING; CELL LINEAGE; CELL MOTILITY; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; ENGRAFTMENT; MESOANGIOBLAST; MOUSE; MUSCLE DEVELOPMENT; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKELETAL MUSCLE; STEM CELL; STEM CELL TRANSPLANTATION;

ADIPONECTIN; ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; RATS; SARCOGLYCANS; STEM CELLS;

EID: 77949445998     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E09-04-0310     Document Type: Article

References (64)

1. Aguiari, P., et al. (2008). High glucose induces adipogenic differentiation of muscle-derived stem cells. Proc. Natl. Acad. Sci. USA 105, 1226-1231.
2. Ando, Y., Inaba, M., Sakaguchi, Y., Tsuda, M., Quan, G. K., Omae, M., Okazaki, K., and Ikehara, S. (2008). Subcutaneous adipose tissue-derived stem cells facilitate colonic mucosal recovery from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats. Inflamm. Bowel Dis. 14, 826-838.
3. Asakura, A., Seale, P., Girgis-Gabardo, A., and Rudnicki, M. A. (2002). Myogenic specification of side population cells in skeletal muscle. J. Cell Biol. 159, 123-134.
4. Bachrach, E., Li, S., Perez, A. L., Schienda, J., Liadaki, K., Volinski, J., Flint, A., Chamberlain, J., and Kunkel, L. M. (2004). Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells. Proc. Natl. Acad. Sci. USA 101, 3581-3586.
5. Berg, A. H., Combs, T. P., and Scherer, P. E. (2002). ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab. 13, 84-89.
6. Brunelli, S., et al. (2004). Msx2 and necdin combined activities are required for smooth muscle differentiation in mesoangioblast stem cells. Circ. Res. 94, 1571-1578.
7. Buckingham, M. (2006). Myogenic progenitor cells and skeletal myogenesis in vertebrates. Curr. Opin. Genet. Dev. 16, 525-532.
8. Chamberlain, G., Fox, J., Ashton, B., and Middleton, J. (2007). Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25, 2739-2749.
9. Cossu, G., and Bianco, P. (2003). Mesoangioblasts-vascular progenitors for extravascular mesodermal tissues. Curr. Opin. Genet. Dev. 13, 537-542.
10. Cossu, G., and Biressi, S. (2005). Satellite cells, myoblasts and other occasional myogenic progenitors: possible origin, phenotypic features and role in muscle regeneration. Semin. Cell Dev. Biol. 16, 623-631.
11. Cossu, G., and Sampaolesi, M. (2004). New therapies for muscular dystrophy: cautious optimism. Trends Mol. Med. 10, 516-520.
12. De Bari, C., Dell'Accio, F., Vandenabeele, F., Vermeesch, J. R., Raymackers, J. M., and Luyten, F. P. (2003). Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J. Cell Biol. 160, 909-918.
13. Delaigle, A. M., Jonas, J. C., Bauche, I. B., Cornu, O., and Brichard, S. M. (2004). Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. Endocrinology 145, 5589-5597.
14. Dellavalle, A., et al. (2007). Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat. Cell Biol. 9, 255-267.
15. Dhawan, J., and Rando, T. A. (2005). Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends Cell Biol. 15, 666-673.
16. DiMascio, L., Voermans, C., Uqoezwa, M., Duncan, A., Lu, D., Wu, J., Sankar, U., and Reya, T. (2007). Identification of adiponectin as a novel hemopoietic stem cell growth factor. J. Immunol. 178, 3511-3520.
17. Donati, C., Cencetti, F., Nincheri, P., Bernacchioni, C., Brunelli, S., Clementi, E., Cossu, G., and Bruni, P. (2007). Sphingosine 1-phosphate mediates proliferation and survival of mesoangioblasts. Stem Cells 25, 1713-1719.
18. Duclos, F., et al. (1998). Progressive muscular dystrophy in alpha-sarcoglycandeficient mice. J. Cell Biol. 142, 1461-1471.
19. Fiaschi, T., Buricchi, F., Cozzi, G., Matthias, S., Parri, M., Raugei, G., Ramponi, G., and Chiarugi, P. (2007). Redox-dependent and ligand-independent transactivation of insulin receptor by globular adiponectin. Hepatology 46, 130-139.
20. Fiaschi, T., Cirelli, D., Comito, G., Gelmini, S., Ramponi, G., Serio, M., and Chiarugi, P. (2009). Globular adiponectin induces differentiation and fusion of skeletal muscle cells. Cell Res. 19, 584-597.
21. Filigheddu, N., et al. (2007). Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol. Biol. Cell 18, 986-994.
22. Galvez, B. G., Sampaolesi, M., Brunelli, S., Covarello, D., Gavina, M., Rossi, B., Constantin, G., Torrente, Y., and Cossu, G. (2006). Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. J. Cell Biol. 174, 231-243.
23. Gilmore, A. P. (2005). Anoikis. Cell Death. Differ. 12(Suppl 2), 1473-1477.
24. Guerre-Millo, M. (2008). Adiponectin: an update. Diabetes Metab. 34, 12-18.
25. Guttinger, M., Tafi, E., Battaglia, M., Coletta, M., and Cossu, G. (2006). Allogeneic mesoangioblasts give rise to alpha-sarcoglycan expressing fibers when transplanted into dystrophic mice. Exp. Cell Res. 312, 3872-3879.
26. Jones, N. C., Tyner, K. J., Nibarger, L., Stanley, H. M., Cornelison, D. D., Fedorov, Y. V., and Olwin, B. B. (2005). The p38alpha/beta MAPK functions as a molecular switch to activate the quiescent satellite cell. J. Cell Biol. 169, 105-116.
27. Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K., and Tobe, K. (2006). Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116, 1784-1792.
28. Kase, H., et al. (2007). Globular adiponectin induces adhesion molecule expression through the sphingosine kinase pathway in vascular endothelial cells. Life Sci. 81, 939-943.
29. LaBarge, M. A., and Blau, H. M. (2002). Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 111, 589-601.
30. Le Grand, F., and Rudnicki, M. A. (2007). Skeletal muscle satellite cells and adult myogenesis. Curr. Opin. Cell Biol. 19, 628-633.
31. Leri, A., Kajstura, J., and Anversa, P. (2005). Cardiac stem cells and mechanisms of myocardial regeneration. Physiol. Rev. 85, 1373-1416.
32. Li, J., and Yuan, J. (2008). Caspases in apoptosis and beyond. Oncogene 27, 6194-6206.
33. Li, Y. P. (2003). TNF-alpha is a mitogen in skeletal muscle. Am. J. Physiol. Cell Physiol. 285, C370-C376.
34. Lihn, A. S., Pedersen, S. B., and Richelsen, B. (2005). Adiponectin: action, regulation and association to insulin sensitivity. Obes. Rev. 6, 13-21.
35. Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta DeltaC(T)) Method. Methods 25, 402-408.
36. Long, M. A., Corbel, S. Y., and Rossi, F. M. (2005). Circulating myogenic progenitors and muscle repair. Semin. Cell Dev. Biol. 16, 632-640.
37. Meredith, J. E., Jr., Fazeli, B., and Schwartz, M. A. (1993). The extracellular matrix as a cell survival factor. Mol. Biol. Cell 4, 953-961.
38. Minasi, M. G., et al. (2002). The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 129, 2773-2783.
39. Nagata, Y., Partridge, T. A., Matsuda, R., and Zammit, P. S. (2006). Entry of muscle satellite cells into the cell cycle requires sphingolipid signaling. J. Cell Biol. 174, 245-253.
40. Oreffo, R. O., Cooper, C., Mason, C., and Clements, M. (2005). Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential. Stem Cell Rev. 1, 169-178.
41. Ouchi, N., and Walsh, K. (2007). Adiponectin as an anti-inflammatory factor. Clin. Chim. Acta 380, 24-30.
42. Partridge, T. A., Morgan, J. E., Coulton, G. R., Hoffman, E. P., and Kunkel, L. M. (1989). Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337, 176-179.
43. Porada, C. D., Zanjani, E. D., and Almeida-Porad, G. (2006). Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr. Stem Cell Res. Ther. 1, 365-369.
44. Qu-Petersen, Z., et al. (2002). Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J. Cell Biol. 157, 851-864.
45. Rasouli, N., and Kern, P. A. (2008). Adipocytokines and the metabolic complications of obesity. J. Clin. Endocrinol. Metab. 93, S64-S73.
46. Reginato, M. J., Mills, K. R., Paulus, J. K., Lynch, D. K., Sgroi, D. C., Debnath, J., Muthuswamy, S. K., and Brugge, J. S. (2003). Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat. Cell Biol. 5, 733-740.
47. Rodriguez, A. M., et al. (2005). Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J. Exp. Med. 201, 1397-1405.
48. Sampaolesi, M., et al. (2006). Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444, 574-579.
49. Sampaolesi, M., et al. (2003). Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 301, 487-492.
50. Sciorati, C., Galvez, B. G., Brunelli, S., Tagliafico, E., Ferrari, S., Cossu, G., and Clementi, E. (2006). Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy. J. Cell Sci. 119, 5114-5123.
51. Sheehan, S. M., and Allen, R. E. (1999). Skeletal muscle satellite cell proliferation in response to members of the fibroblast growth factor family and hepatocyte growth factor. J. Cell. Physiol. 181, 499-506.
52. Sherwood, R. I., Christensen, J. L., Conboy, I. M., Conboy, M. J., Rando, T. A., Weissman, I. L., and Wagers, A. J. (2004). Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. Cell 119, 543-554.
53. Shibata, R., Skurk, C., Ouchi, N., Galasso, G., Kondo, K., Ohashi, T., Shimano, M., Kihara, S., Murohara, T., and Walsh, K. (2008). Adiponectin promotes endothelial progenitor cell number and function. FEBS Lett. 582, 1607-1612.
54. Tamaki, T., Akatsuka, A., Ando, K., Nakamura, Y., Matsuzawa, H., Hotta, T., Roy, R. R., and Edgerton, V. R. (2002). Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J. Cell Biol. 157, 571-577.
55. Torrente, Y., et al. (2004). Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J. Clin. Invest 114, 182-195.
56. Vignaud, A., Ramond, F., Hourde, C., Keller, A., Butler-Browne, G., and Ferry, A. (2007). Diabetes provides an unfavorable environment for muscle mass and function after muscle injury in mice. Pathobiology 74, 291-300.
57. Volonte, D., Liu, Y., and Galbiati, F. (2005). The modulation of caveolin-1 expression controls satellite cell activation during muscle repair. FASEB J. 19, 237-239.
58. Wagers, A. J., and Conboy, I. M. (2005). Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell 122, 659-667.
59. Waki, H., Yamauchi, T., Kamon, J., Kita, S., Ito, Y., Hada, Y., Uchida, S., Tsuchida, A., Takekawa, S., and Kadowaki, T. (2005). Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 146, 790-796.
60. Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., and Tataranni, P. A. (2001). Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86, 1930-1935.
61. Yamauchi, T., et al. (2003). Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762-769.
62. Yamauchi, T., et al. (2002). Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288-1295.
63. Yamauchi, T., et al. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7, 941-946.
64. Yamauchi, T., et al. (2007). Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13, 332-339.